Zeng, QiqunHanahan, Douglas2020-12-022020-12-022020-12-022020https://infoscience.epfl.ch/handle/20.500.14299/173796The present invention provides compositions and methods for down-modulating the expression and/or the immuno-suppressive activity of i) the FMRP protein, ii) an mRNA encoding the FMRP protein, and/or iii) the FMR1 gene for the treatment and/or prevention of primary cancer and/or cancer metastasis in a subject in need thereof.patentUS2023227823US11473087JP2022532303EP3966326CN113784731AU2020269398CA3137667US2020354718WO202022530966439945